Tianzhihang announced that the company plans to issue shares to purchase 62% of Shanghai Minimally Invasive Orthopedic Medical Technology Co., Ltd. and raise supporting capital. The transaction is expected to constitute a major asset restructuring and related transaction. After the transaction is completed, the bid company will become the company's holding subsidiary. Trading of the company's shares resumed on July 30, 2026. As of the disclosure date of this announcement, the audit and evaluation work involved in this transaction is progressing in an orderly manner. The transaction still needs to be reviewed by the company's board of directors and shareholders' meeting, reviewed and approved by the Shanghai Stock Exchange and registered by the Securities Regulatory Commission. There is uncertainty about whether and when it will be approved.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.